fashion -WSS

fashion

author：focus 2025-10-01 17:35:15 - browse：581

A purple number 3 with an eye is surrounded by smaller, black number 3s on a green background — 3 to watch coverage from STAT — Christine Kao/STAT

Every winter, like Punxsutawney nobles, biotech’s many thought leaders gather for the J.P. Morgan Healthcare Conference to pick apart the year that was and prognosticate about the one to come. The consensus, in good markets and bad, is almost always cautious optimism for boom times ahead, a prediction that in recent years has had groundhog-level accuracy.

But after two years of steady decline, 2024 might finally prove them right. Biotech is on the upswing, driven by the rise of some headline-grabbing medicines, the advance of cutting-edge technologies, and a few reminders that big drug companies are still willing to pay billions of dollars for small ones.

Here are three major themes that we expect to drive the news in 2024 and determine whether biotech’s comeback is a sustainable trend or an interest-rate phenomenon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Humana’s losses in Medicare Advantage tank its stock

leisure time

entertainment

WSS

Zyn nicotine pouches become unlikely player in latest culture war

Medical mystery: When an infection after surgery isn’t what it seems

Vertex non

Wegovy leads to weight loss. Can it treat depression, too?

Medical schools are missing the mark on artificial intelligence

Merck CEO won’t testify in Senate, citing no expertise in drug prices

focus

fashion

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Russian court extends detention of American musician

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Slain Parkland victim's father speaks out following reenactment

Medicare details structure of new drug price negotiation program

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

ChatGPT in medicine: STAT answers readers' burning questions

What to know about 'Guardians of the Galaxy Vol. 3' as it hits Disney+

Continuity nursing helped my family in our darkest PICU moments

Bernie Sanders is gearing up to subpoena pharma CEOs

entertainment

Prosecutors seek bail revocation for FTX founder Sam Bankman

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Scientists find bacteria from stomach of ancient iceman

Health Care Service Corp to buy Cigna Medicare Advantage plans

Pharma needs to include young adults in clinical research

White House pharmacy plagued with problems, investigation finds

leisure time

entertainment

knowledge

explore